Stock Chart
RZLT
Type: SELL wallstreet
Strike: $5
Premium: $1.65
Expiry: Jan 15, 2027
Target: $5
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About RZLT - Rezolute, Inc. Common Stock (NV)
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue …
Key Statistics
More RZLT Analysis
This RZLT stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track RZLT's price movements with trendlines, gamma walls, and key support/resistance levels.